This report contains market size and forecasts of Decentralized/POC Coagulation Testing in China, including the following market information:
China Decentralized/POC Coagulation Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Decentralized/POC Coagulation Testing companies in 2020 (%)
The global Decentralized/POC Coagulation Testing market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Decentralized/POC Coagulation Testing market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Decentralized/POC Coagulation Testing Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Decentralized/POC Coagulation Testing Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China Decentralized/POC Coagulation Testing Market Segment Percentages,

By Type

, 2020 (%)
Anti-Coagulated Plasma Technology
Whole Blood Specimen Testing Kits
Satellite Anticoagulation Therapy

China Decentralized/POC Coagulation Testing Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China Decentralized/POC Coagulation Testing Market Segment Percentages,

By Application

, 2020 (%)
Hospitals
Ambulatory Surgical Centers
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decentralized/POC Coagulation Testing revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Decentralized/POC Coagulation Testing revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott Laboratories
Biosite Diagnostic
Medtronic
Trinity Biotech
Polartechnics